{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-048065","form_type":"8-K","ticker":"VVOS","cik":"0001716166","company_name":"Vivos Therapeutics, Inc.","filed_at":"2024-11-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.341380+00:00","generated_at":"2026-05-29T14:52:40.130388+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Vivos stockholders elect all director nominees and approve 2024 equity plan at annual meeting","bullets":["Six directors elected: Huntsman, Green, Krammer, Lindsay, Sokolow, Thompson; each received ~1.1M for, ~155-193K withheld.","2024 Omnibus Equity Incentive Plan approved with 957,268 for, 313,560 against, 17,747 abstentions.","Ratification of Moss Adams LLP as auditor for FY2024 passed with 2,496,723 for, 162,219 against, 35,623 abstentions.","Approximately 2.7M of 4.8M outstanding shares voted, constituting a quorum."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-048065","json":"https://secwatch.observer/filing/0001493152-24-048065.json","markdown":"https://secwatch.observer/filing/0001493152-24-048065.md","text":"https://secwatch.observer/filing/0001493152-24-048065.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1716166/000149315224048065/0001493152-24-048065-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1716166/000149315224048065/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T14:52:40.130388+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}